Features of immune response in patients with post-COVID syndrome and a history of type 6 herpes
- Authors: Verkhovskaya M.D.1, Marchenko V.S.2
-
Affiliations:
- Federal Research Institute of Viral Infections “Virom”
- Chelyabinsk State University
- Issue: Vol 28, No 3 (2025)
- Pages: 695-702
- Section: SHORT COMMUNICATIONS
- URL: https://journal-vniispk.ru/1028-7221/article/view/319921
- DOI: https://doi.org/10.46235/1028-7221-17209-FOI
- ID: 319921
Cite item
Full Text
Abstract
Since the end of 2019, people have been faced with infection, caused by a new strain of coronavirus – SARS-CoV-2. This disease has led to a pandemic, one of the global problems of mankind. Despite clinical manifestations of COVID-19 became milder with time, resembling features of seasonal viral infections, the persistent disturbances in various organs and systems were identified in former patients. It was found that, after suffering from COVID-19, a significant number of patients experience numerous disorders in both general health and complications of existing chronic diseases, including herpesvirus reactivation nd papillomavirus infection. In this regard, the scientific community has an additional task, a comprehensive and in-depth study of post-COVID syndrome to identify ways to improve the condition of patients. Currently, it has been revealed that about 90% of the world’s population is infected with herpesviruses. In some cases, one person may be found to have co-infection with different herpesviruses. Herpesvirus infections may be associated with a lot of conditions, from local labial herpes to generalized forms, malignant neoplasms and congenital malformations. It can occur both in acute and latent forms. The study of herpesvirus infection in the context of post-covid syndrome is one of the most pressing problems of modern medicine. The purpose of this study was to evaluate the changes in immune indexes in patients with post-COVID syndrome and with laboratory and clinically confirmed herpes virus type 6. To this purpose, changes in innate immune response indicators such as the complement system, phagocytic activity of neutrophils were assessed. Clinical data, immunological tests (enzyme-linked immunosorbent assay and NBT test with nitroblue tetrazolium), and statistical analysis methods (Mann–Whitney criterion) were used for the study. The results have shown that that adverse reactions caused by the previous coronavirus infection are characterized by new aspects of disorders in adaptive and innate immune systems, thus leading to more serious consequences for immune system and the entire body, having been carefully studied and analyzed. The revealed changes indicate that the more pronounced disorders are observed in patients with post-COVID syndrome and a history of herpes virus type 6. This finding highlights the need for a more detailed study of their immune status, in order to develop individualized approaches to immunocorrection of immune system disorders in this group of patients, taking into account their herpesvirus history.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Maria D. Verkhovskaya
Federal Research Institute of Viral Infections “Virom”
Author for correspondence.
Email: maria.verh1@mail.ru
Junior Researcher, Laboratory of Transmissible Viral Infections
Russian Federation, EkaterinburgV. S. Marchenko
Chelyabinsk State University
Email: maria.verh1@mail.ru
Student, Faculty of Fundamental Medicine
Russian Federation, ChelyabinskReferences
- Добрынина М.А., Зурочка А.В., Зурочка В.А., Клиника-иммунологическая характеристика постковидных пациентов с инфекционным синдромом иммунопатологии // Российский иммунологический журнал, 2024. Т. 27, № 3. С. 689-698. [Dobrynina M.A., Zurochka A.V., Zurochka V.A. Clinical and immunological characteristics of post-COVID patients with infectious immunopathology syndrome. Rossiyskiy Immunologicheskiy Zhurnal = Russian Journal of Immunology, 2024, Vol. 27, no. 3, pp. 689-698. (In Russ.)] doi: 10.46235/1028-7221-16845-CAI.
- Иоселиани Д.Г. Что такое COVID-19? // Международный журнал интервенционной кардиоангиологии, 2020. № 61. С. 11-34. [Ioseliani D.G. What is COVID-19? Mezhdunarodnyy zhurnal interventsionnoy kardioangiologii = International Journal of Interventional Cardioangiology, 2020, no. 61, pp. 11-34. (In Russ.)]
- Канорский С.Г. Постковидный синдром: распространенность и патогенез органных поражений, направления коррекции. Систематический обзор // Кубанский научный медицинский вестник, 2021. Т. 28, № 6. С. 90-116. [Kanorskiy S.G. Postcovoid syndrome: prevalence and pathogenesis of organ lesions, directions of correction. A systematic review. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Scientific Medical Bulletin, 2021, Vol. 28, no. 6, pp. 90-116. (In Russ.)]
- Козлов В.А., Тихонова Е.П., Савченко А.А., Кудрявцев И.В., Андронова Н.В., Анисимова Е.Н., Головкин А.С., Демина Д.В., Здзитовецкий Д.Э., Калинина Ю.С., Каспаров Э.В., Козлов И.Г., Корсунский И.А., Кудлай Д.А., Кузьмина Т.Ю., Миноранская Н.С., Продеус А.П., Старикова Э.А., Черданцев Д.В., Чесноков А.Б., Шестерня П.А., Борисов А.Г. Клиническая иммунология: практическое пособие для инфекционистов. Красноярск: Поликор, 2021. 563 с. [Kozlov V.A., Tikhonova E.P., Savchenko A.A., Kudryavtsev I.V., Andronova N.V., Anisimova E.N., Golovkin A.S., Demina D.V., Zdzitovetsky D.E., Kalinina Yu.S., Kasparov E.V., Kozlov I.G., Korsunsky I.A., Kudlay D.A., Kuzmina T.Yu., Minoranskaya N.S., Prodeus A.P., Starikova E.A., Cherdantsev D.V., Chesnokov A.B., Shesternya P.A., Borisov A.G. Clinical immunology: A practical guide for infectious diseases specialists]. Krasnoyarsk: Polikor, 2021. 563 p.
- Оперативная информация о распространении новой коронавирусной инфекции (COVID-19) по территориям, обслуживаемым ФМБА России. [Электронный ресурс]. Режим доступа: https://fmba.gov.ru/covid-19/informatsiya-o-novoy-koronavirusnoy-infektsii/. [Operational information on the spread of the new coronavirus infection (COVID-19) in the territories served by the FMBA of Russia. [Electronic resource]. Available at: https://fmba.gov.ru/covid-19/informatsiya-o-novoy-koronavirusnoy-infektsii/].
- Пронькина Н.С., Булыгин Г.В., Камзалакова Н.И., Тихонова Ю.С. Характеристика параметров иммунного статуса у больных хронической герпетической инфекцией с формированием синдрома хронической усталости и иммунной дисфункции // Вестник Санкт-Петербургского университета. Медицина, 2015. № 2. C. 52-58. [Pronkina N.S., Bulygin G.V., Kamzalakova N.I., Tikhonova Yu.S. Characteristics of immune status parameters in patients with chronic herpes infection with the formation of chronic fatigue syndrome and immune dysfunction. Vestnik Sankt-Peterburgskogo universiteta. Meditsina = Bulletin of St. Petersburg University. Medicine, 2015. no. 2, pp. 52-58. (In Russ.)]
- Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19): временные методические рекомендации. М., 2021. 225 c. [Электронный ресурс]. Режим доступа: https://medkirovdpo.ru/ uploads/docs/2021/временные_методические_рекомендации_covid_19_v11.pdf. [Prevention, diagnosis and treatment of new coronavirus infection (COVID-19): temporary methodological recommendations. Moscow, 2021. 225 p. [Electronic resource]. Available at: https://medkirovdpo.ru/uploads/docs/2021/временные_методические_рекомендации_covid_19_v11.pdf].
- Ablashi D.V., Salahuddin S.Z., Josephs S.F., Imam F., Lusso P., Gallo R.C., Hung C., Lemp J., Markham P.D. HBLV (or HHV-6) in human cell lines. Nature, 1987, Vol. 329, no. 6136, 207. doi: 10.1038/329207a0.
- Agut H. Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. J. Clin. Virol., 2011, Vol. 52, no. 3, pp. 164-171
- Agut H., Bonnafous P., Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin. Microbiol. Rev., 2015, Vol. 28, no. 2, pp. 313-335.
- Caserta M.T., McDermott M.P., Dewhurst S., Schnabel K., Carnahan J.A., Gilbert L., Lathan G., Lofthus G.K., Hall C.B. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children. J. Pediatr., 2004, Vol. 145, no. 4, pp. 478-484.
- Nalbandian A., Sehgal K., Gupta. A., Madhavan M.V, McGroder. C., Stevens. J.S, Cook. J.R, Nordvig. A.S, Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat Med. 2021, pp. 601-615.
- Oronsky B, Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A review of persistent Post-COVID Syndrome (PPCS). Clin. Rev. Allergy Immunol., 2023, Vol. 64, no. 1, pp. 66-74.
- Paces J, Strizova Z., Smrz D., Cerny J. COVID-19 and the immune system. Physiol. Res., 2020, Vol. 69, no. 3, pp. 379-388.
- Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J. Transl. Med., 2018, Vol. 16, no. 1, 268. doi: 10.1186/s12967-018-1644-y.
- Sarah S., Larry K., Charles G. Principles and practice of pediatric infectious diseases. Prober Churchill Livingstone Inc., 1997.
- Vojdani A., Vojdani E., Saidara E., Maes M. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses, 2023, Vol. 15, no. 2, 400. doi: 10.3390/v15020400.
- WHO Coronavirus (COVID-19) dashboard. COVID-19 deaths (dashboard). Available at: https://data.who.int/dashboards/covid19/cases?n=o
- Zubchenko S., Kril I., Nadizhko O., Matsyura O., Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational stud. Rheumatol. Int., 2022, Vol. 42, no. 9, pp. 1523-1530.
Supplementary files
